Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer

Figure 6

Stability of presacral CRC metastatic lesion on PARP inhibitor therapy. Axial computed tomography scans during treatment are provided: (a) July 2017, (b) April 2018, (c) November 2018, and (d) August 2019.

(a)

(b)

(c)

(d)